NO20083695L - Meridamycin analoger for behandlingen av neurodegenererende sykdommer - Google Patents
Meridamycin analoger for behandlingen av neurodegenererende sykdommerInfo
- Publication number
- NO20083695L NO20083695L NO20083695A NO20083695A NO20083695L NO 20083695 L NO20083695 L NO 20083695L NO 20083695 A NO20083695 A NO 20083695A NO 20083695 A NO20083695 A NO 20083695A NO 20083695 L NO20083695 L NO 20083695L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- neurodegenerative diseases
- meridamycin
- analogues
- meridamycin analogues
- Prior art date
Links
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- UNSKIISCJFJWTL-WIDVRGBZSA-N meridamycin Chemical class C1C(O)C(C)C(O)CC(O)CC(O)\C(C)=C\C(C)CC(C)C(O)C(/CC)=C/CC(C(\C)=C\C(C)C(C)O)OC(=O)C2CCCN2C(=O)C(=O)C2(O)C(C)CCC1O2 UNSKIISCJFJWTL-WIDVRGBZSA-N 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77994006P | 2006-03-07 | 2006-03-07 | |
| PCT/US2007/005645 WO2007103347A1 (en) | 2006-03-07 | 2007-03-05 | Meridamycin analogues for the treatment of neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083695L true NO20083695L (no) | 2008-10-03 |
Family
ID=38289934
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083695A NO20083695L (no) | 2006-03-07 | 2008-08-27 | Meridamycin analoger for behandlingen av neurodegenererende sykdommer |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7745457B2 (pt) |
| EP (1) | EP1991551A1 (pt) |
| JP (1) | JP2009529049A (pt) |
| KR (1) | KR20080099317A (pt) |
| CN (1) | CN101426796A (pt) |
| AR (1) | AR059738A1 (pt) |
| AU (1) | AU2007223962A1 (pt) |
| BR (1) | BRPI0708611A2 (pt) |
| CA (1) | CA2643350A1 (pt) |
| CR (1) | CR10272A (pt) |
| EC (1) | ECSP088718A (pt) |
| IL (1) | IL193414A0 (pt) |
| MX (1) | MX2008011312A (pt) |
| NO (1) | NO20083695L (pt) |
| PE (1) | PE20081550A1 (pt) |
| RU (1) | RU2008132779A (pt) |
| TW (1) | TW200804400A (pt) |
| WO (1) | WO2007103347A1 (pt) |
| ZA (1) | ZA200807678B (pt) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2007119585A (ru) * | 2004-12-20 | 2009-01-27 | Вайет (Us) | Производные рапамицина и их применение при лечении неврологических заболеваний |
| SG158143A1 (en) * | 2004-12-20 | 2010-01-29 | Wyeth Corp | Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9302016D0 (en) | 1993-02-02 | 1993-03-17 | Sandoz Ltd | Compounds |
| GB9318144D0 (en) | 1993-09-01 | 1993-10-20 | Sandoz Ltd | Organic compounds |
| WO1995014023A1 (en) | 1993-11-19 | 1995-05-26 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| CA2556771A1 (en) * | 2004-03-02 | 2005-09-15 | Wyeth | Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents |
| EP1720886A1 (en) * | 2004-03-02 | 2006-11-15 | Wyeth | Macrolides and methods for producing same |
| US7507752B2 (en) * | 2004-06-03 | 2009-03-24 | Wyeth | Biosynthetic gene cluster for the production of a complex polyketide |
| WO2006053313A2 (en) * | 2004-11-12 | 2006-05-18 | Wyeth | Elaiophylin biosynthetic gene cluster |
| RU2007119585A (ru) | 2004-12-20 | 2009-01-27 | Вайет (Us) | Производные рапамицина и их применение при лечении неврологических заболеваний |
| SG158143A1 (en) | 2004-12-20 | 2010-01-29 | Wyeth Corp | Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative, and inflammatory disorders |
-
2007
- 2007-03-05 KR KR1020087021820A patent/KR20080099317A/ko not_active Withdrawn
- 2007-03-05 CA CA002643350A patent/CA2643350A1/en not_active Abandoned
- 2007-03-05 AU AU2007223962A patent/AU2007223962A1/en not_active Abandoned
- 2007-03-05 MX MX2008011312A patent/MX2008011312A/es not_active Application Discontinuation
- 2007-03-05 EP EP07752355A patent/EP1991551A1/en not_active Withdrawn
- 2007-03-05 AR ARP070100899A patent/AR059738A1/es unknown
- 2007-03-05 US US11/713,972 patent/US7745457B2/en not_active Expired - Fee Related
- 2007-03-05 WO PCT/US2007/005645 patent/WO2007103347A1/en not_active Ceased
- 2007-03-05 RU RU2008132779/04A patent/RU2008132779A/ru not_active Application Discontinuation
- 2007-03-05 TW TW096107510A patent/TW200804400A/zh unknown
- 2007-03-05 JP JP2008558346A patent/JP2009529049A/ja active Pending
- 2007-03-05 BR BRPI0708611-3A patent/BRPI0708611A2/pt not_active Application Discontinuation
- 2007-03-05 CN CNA2007800078343A patent/CN101426796A/zh active Pending
- 2007-03-09 PE PE2007000263A patent/PE20081550A1/es not_active Application Discontinuation
-
2008
- 2008-08-12 IL IL193414A patent/IL193414A0/en unknown
- 2008-08-27 NO NO20083695A patent/NO20083695L/no not_active Application Discontinuation
- 2008-09-05 ZA ZA200807678A patent/ZA200807678B/xx unknown
- 2008-09-05 EC EC2008008718A patent/ECSP088718A/es unknown
- 2008-09-05 CR CR10272A patent/CR10272A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200804400A (en) | 2008-01-16 |
| IL193414A0 (en) | 2009-05-04 |
| MX2008011312A (es) | 2008-09-12 |
| AR059738A1 (es) | 2008-04-23 |
| AU2007223962A1 (en) | 2007-09-13 |
| KR20080099317A (ko) | 2008-11-12 |
| BRPI0708611A2 (pt) | 2011-06-07 |
| CR10272A (es) | 2008-10-03 |
| US20070213525A1 (en) | 2007-09-13 |
| PE20081550A1 (es) | 2008-12-31 |
| CN101426796A (zh) | 2009-05-06 |
| EP1991551A1 (en) | 2008-11-19 |
| US7745457B2 (en) | 2010-06-29 |
| ZA200807678B (en) | 2009-08-26 |
| ECSP088718A (es) | 2008-10-31 |
| CA2643350A1 (en) | 2007-09-13 |
| WO2007103347A1 (en) | 2007-09-13 |
| JP2009529049A (ja) | 2009-08-13 |
| RU2008132779A (ru) | 2010-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1500058I1 (hu) | Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére | |
| LT2878297T (lt) | Medikamentai, skirti fibrozinių ligų gydymui arba prevencijai | |
| NO20081527L (no) | Anvendelse av flibanserin for behandling av pre-menopausal seksuell lyst forstyrrelser | |
| IL260117A (en) | Use of placental cells to treat diseases, syndromes or conditions of the lungs | |
| CY2016015I2 (el) | Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων | |
| WO2009064388A3 (en) | Inhibitors of human methionine aminopeptidase 1 and methods of treating disorders | |
| UA115320C2 (uk) | Інгібітори кінази | |
| WO2007087468A3 (en) | Adiponectin for treatment of various disorders | |
| WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
| CL2007003520A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer. | |
| IL190338A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| EA201100335A1 (ru) | Производные пурина для применения при лечении связанных с fab заболеваний | |
| IL190652A0 (en) | Novel pharmaceutical combinations for the treatment of respiratory disorders | |
| IL192415A0 (en) | Pharmaceutical composition for the treatment of nail diseases | |
| NO20065535L (no) | Behandling av respiratorisk sykdom | |
| AU2012308243A8 (en) | Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury | |
| TWI369988B (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| WO2008037937A3 (fr) | Utilisation de composes de la famille des milbemycines pour le traitement de desordres dermatologiques chez l'homme | |
| EA200900923A1 (ru) | Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний | |
| MX2008011312A (es) | Analogos de meridamicina para el tratamiento de trastornos neurodegenerativos. | |
| TWI365753B (en) | Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases | |
| WO2007107696A3 (en) | Pharmaceutically acceptable salts and polymorphic forms | |
| EP1864671A4 (en) | USE OF HYDROCHLORIC ACID FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF HYPERTENSION | |
| SI1842537T1 (sl) | Uporaba anti aterotrombotične spojine za pripravo zdravil namenjenih za zdravljenje cerebrovaskularnih motenj | |
| TH0701005484B (th) | ตัวเร่งการสมานของร่างกายสิ่งมีชีวิต |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |